Assessing IL-17 levels in patients with spondyloarthritis
Official title: Feasibility of an Il-17a Assay and Impact on Therapeutic Response in Patients With Active Axial Spondyloarthritis
Run by Centre Hospitalier Universitaire de Nice · NCT05592574 · Data updated 2026-11-12
This study is testing if measuring IL-17 levels in patients with active spondyloarthritis can help doctors choose the best biological treatment after other medications haven't worked.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 1 site (Nice) |
| Status | Recruiting |
| Started | February 1, 2021 |
| Main results expected | January 31, 2041 |
| Study ends | January 31, 2041 |
| Registry record updated | October 24, 2022 |
| Trial ID | NCT05592574 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with active spondyloarthritis who have not responded to at least two NSAIDs and meet the ASAS criteria.
✕Probably not a fit
Patients with predominant axial manifestations or those who have previously received biological treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the feasibility of measuring IL-17 cytokine levels in patients with active spondyloarthritis (axSpA) who require biological treatment after failing at least two non-steroidal anti-inflammatory drugs (NSAIDs). By stimulating immune cells and analyzing cytokine responses, the study seeks to develop a tool that could assist clinicians in selecting the most appropriate biologic therapy for these patients. The study focuses on patients meeting the ASAS criteria for spondyloarthritis and aims to address the lack of validated biomarkers in this area.
Why it matters
Potential benefit: If successful, this study could provide a valuable tool for clinicians to make more informed decisions regarding biologic treatments for patients with spondyloarthritis.
How similar studies have gone: While there have been head-to-head studies comparing biologics in related conditions, this specific approach to cytokine measurement in spondyloarthritis is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Patients with spondyloarthritis meeting the ASAS criteria * Patients who were to benefit from the implementation of a biological treatment after failure of at least two NSAIDs. * Patients having an active disease defined by a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) higher than four, Exclusion criteria * No predominant axial manifestation, * Having received a previous biological treatment * Patients presenting contraindication to the implementation of these treatments.
Where it's running
-
CHU de NICE
Nice, France Recruiting
Study contacts
- Study coordinator: Christian ROUX
- Email: roux.c2@chu-nice.fr
- Phone: +33492035491
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Surface topography and spine damage in radiographic axial spondyloarthritis
This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
Observational cohort for patients with uveitis and spondyloarthritis
This study is tracking patients with uveitis to see how it relates to spondyloarthritis and to learn more about their symptoms and treatment options.
-
Comparing different flexibility rods for treating degenerative lumbar spine diseases
This study is testing whether different types of flexibility rods can help people with degenerative lumbar spine issues feel less back pain and improve their functionality over time.
-
FAPI‑74 PET/CT versus FDG PET/CT for inflammation in FUO, IgG4‑RD, and axial spondyloarthritis
This project will test whether [18F]-AlF-FAPI-74 PET/CT finds inflammation more accurately than standard [18F]-FDG PET/CT in people with fever of unknown origin, IgG4‑related disease, or axial spondyloarthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.